Detalles de la búsqueda
1.
Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.
Phytother Res
; 36(2): 996-1012, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041248
2.
A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Nutr J
; 12: 100, 2013 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23866813
3.
Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents.
Medicines (Basel)
; 4(4)2017 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29165401
4.
Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial.
Psychopharmacology (Berl)
; 234(3): 403-420, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27921139
5.
A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
Complement Ther Med
; 29: 56-62, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27912958
6.
A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).
Nutrients
; 7(12): 9931-45, 2015 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633481
Resultados
1 -
6
de 6
1
Próxima >
>>